Basic Study
Copyright ©The Author(s) 2025.
World J Stem Cells. Apr 26, 2025; 17(4): 100359
Published online Apr 26, 2025. doi: 10.4252/wjsc.v17.i4.100359
Figure 4
Figure 4 miR-137-3p bolstered the migratory and differentiation propensities of human umbilical cord mesenchymal stem cell into endometrial epithelial cell, an effect mitigated by signal transducer and activator of transcription 3 inhibition. Human umbilical cord mesenchymal stem cell, transfected with miR-137-3p mimic or negative control (mimic NC), were exposed to the STAT3 inhibitor Stattic. A: Transwell assays were conducted to evaluate migratory ability. Scale bar = 100 μm, n = 3; B: Wound healing assays were utilized to assess the migratory response of human umbilical cord mesenchymal stem cell. Scale bar = 200 μm, n = 3; C: The protein levels of CD9, CK19, vimentin, and CD13. The results are illustrated as mean ± SD. aP < 0.0001 vs negative control mimic group, bP < 0.0001 vs negative control mimic group, cP < 0.0001 vs miR-137-3p mimic group, dP < 0.0001 vs negative control mimic + Stattic group, n = 3. HucMSC: Human umbilical cord mesenchymal stem cell; NC: Negative control.